Wealth Enhancement Advisory Services’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
Other funds holding ENTA
Wealth Enhancement Advisory Services's ENTA Position: Q3 2026 in Review
Wealth Enhancement Advisory Services reduced its Enanta Pharmaceuticals (ENTA) stake by 11% in Q3 2026, selling an estimated $19.6K and leaving 11,836 shares worth $143K. The position accounts for ﹤0.01% of the portfolio, ranked #3853.
Wealth Enhancement Advisory Services first reported a position in ENTA in Q2 2025 and has held it in 6 quarters since. The position peaked at $182K in Q2 2026. 129 funds tracked by Wall St. Rank hold ENTA as of Q3 2026.
- Wealth Enhancement Advisory Services held 11,836 shares of Enanta Pharmaceuticals worth $143K as of Q3 2026.
- Wealth Enhancement Advisory Services sold 1,479 Enanta Pharmaceuticals shares in Q3 2026, an estimated $19.6K.
- Enanta Pharmaceuticals made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q3 2026, its #3853 holding.
- Wealth Enhancement Advisory Services first reported a position in Enanta Pharmaceuticals in Q2 2025 and has held it in 6 quarters since.
- Wealth Enhancement Advisory Services's Enanta Pharmaceuticals position peaked at $182K in Q2 2026.
- 129 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q3 2026.
Based on Wealth Enhancement Advisory Services's 13F filing for Q3 2026, filed 13 Oct 2026.